Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' CHARLESON S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 22 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Riendeau, D; Percival, MD; Brideau, C; Charleson, S; Dube, D; Ethier, D; Falgueyret, JP; Friesen, RW; Gordon, R; Greig, G; Guay, J; Mancini, J; Ouellet, M; Wong, E; Xu, L; Boyce, S; Visco, D; Girard, Y; Prasit, P; Zamboni, R; Rodger, IW; Gresser, M; Ford-Hutchinson, AW; Young, RN; Chan, CC
      Etoricoxib (MK-0663): Preclinical profile and comparison with other agentsthat selectively inhibit cyclooxygenase-2

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    2. Li, CS; Black, WC; Brideau, C; Chan, CC; Charleson, S; Cromlish, WA; Claveau, D; Gauthier, JY; Gordon, R; Greig, G; Grimm, E; Guay, J; Lau, CK; Riendeau, D; Therien, M; Visco, DM; Wong, E; Xu, LJ; Prasit, P
      A new structural variation on the methanesulfonylphenyl class of selectivecyclooxygenase-2 inhibitors

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    3. Lau, CK; Brideau, C; Chan, CC; Charleson, S; Cromlish, WA; Ethier, D; Gauthier, JY; Gordon, R; Guay, J; Kargman, S; Li, CS; Prasit, P; Riendeau, D; Therien, M; Visco, DM; Xu, LJ
      Synthesis and biological evaluation of 3-heteroarizoxy-4-phenyl-2(5H)-furanones as selective COX-2 inhibitors

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    4. Ouimet, N; Chan, CC; Charleson, S; Claveau, D; Gordon, R; Guay, D; Li, CS; Ouellet, M; Percival, DM; Riendeau, D; Wong, E; Zamboni, R; Prasit, P
      Substituted heterocyclic analogs as selective COX-2 inhibitors in the Flosulide class

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    5. Frenette, R; Hutchinson, JH; Leger, S; Therien, M; Brideau, C; Chan, CC; Charleson, S; Ethier, D; Guay, J; Jones, TR; McAuliffe, M; Piechuta, H; Riendeau, D; Tagari, P; Girard, Y
      Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitors

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    6. Leblanc, Y; Roy, P; Boyce, S; Brideau, C; Chan, CC; Charleson, S; Gordon, R; Grimm, E; Guay, J; Leger, S; Li, CS; Riendeau, D; Visco, D; Wang, Z; Webb, J; Xu, LJ; Prasit, P
      Sar in the alkoxy lactone series: The discovery of DFP, a potent and orally active COX-2 inhibitor

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    7. Prasit, P; Wang, Z; Brideau, C; Chan, CC; Charleson, S; Cromlish, W; Ethier, D; Evans, JF; Ford-Hutchinson, AW; Gauthier, JY; Gordon, R; Guay, J; Gresser, M; Kargman, S; Kennedy, B; Leblanc, Y; Leger, S; Mancini, J; O'Neill, GP; Ouellet, M; Percival, MD; Perrier, H; Riendeau, D; Rodger, I; Tagari, P; Therien, M; Vickers, P; Wong, E; Xu, LJ; Young, RN; Zamboni, R; Boyce, S; Rupniak, N; Forrest, N; Visco, D; Patrick, D
      The discovery of rofecoxib, [MK 966, Vioxx (R), 4-(4 '-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    8. Chan, CC; Boyce, S; Brideau, C; Charleson, S; Cromlish, W; Ethier, D; Evans, J; Ford-Hutchinson, AW; Forrest, MJ; Gauthier, JY; Gordon, R; Gresser, M; Guay, J; Kargman, S; Kennedy, B; Leblanc, Y; Leger, S; Mancini, J; O'Neill, GP; Ouellet, M; Patrick, D; Percival, MD; Perrier, H; Prasit, P; Rodger, I; Tagari, P; Therien, M; Vickers, P; Visco, D; Wang, Z; Webb, J; Wong, E; Xu, LJ; Young, RN; Zamboni, R; Riendeau, D
      Rofecoxib [Vioxx, MK-0966; 4-(4 '-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    9. Black, WC; Brideau, C; Chan, CC; Charleson, S; Chauret, N; Claveau, D; Ethier, D; Gordon, R; Greig, G; Guay, J; Hughes, G; Jolicoeur, P; Leblanc, Y; Nicoll-Griffith, D; Ouimet, N; Riendeau, D; Visco, D; Wang, ZY; Xu, L; Prasit, P
      2,3-diarylcyclopentenones as orally active, highly selective cyclooxygenase-2 inhibitors

      JOURNAL OF MEDICINAL CHEMISTRY
    10. FRIESEN RW; BRIDEAU C; CHAN CC; CHARLESON S; DESCHENES D; DUBE D; ETHIER D; FORTIN R; GAUTHIER JY; GIRARD Y; GORDON R; GREIG GM; RIENDEAU D; SAVOIE C; WANG ZY; WONG E; VISCO D; XU LJ; YOUNG RN
      2-PYRIDINYL-3-(4-METHYLSULFONYL)PHENYLPYRIDINES - SELECTIVE AND ORALLY-ACTIVE CYCLOOXYGENASE-2 INHIBITORS

      Bioorganic & medicinal chemistry letters
    11. WONG E; DELUCA C; BOILY C; CHARLESON S; CROMLISH W; DENIS D; KARGMAN S; KENNEDY BP; OUELLET M; SKOREY K; ONEILL GP; VICKERS PJ; RIENDEAU D
      CHARACTERIZATION OF AUTOCRINE INDUCIBLE PROSTAGLANDIN-H SYNTHASE-2 (PGHS-2) IN HUMAN OSTEOSARCOMA CELLS

      Inflammation research
    12. RIENDEAU D; CHARLESON S; CROMLISH W; MANCINI JA; WONG E; GUAY J
      COMPARISON OF THE CYCLOOXYGENASE-1 INHIBITORY PROPERTIES OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS (NSAIDS) AND SELECTIVE COX-2 INHIBITORS, USING SENSITIVE MICROSOMAL AND PLATELET ASSAYS

      Canadian journal of physiology and pharmacology
    13. RIENDEAU D; PERCIVAL MD; BOYCE S; BRIDEAU C; CHARLESON S; CROMLISH W; ETHIER D; EVANS J; FALGUEYRET JP; FORDHUTCHINSON AW; GORDON R; GREIG G; GRESSER M; GUAY J; KARGMAN S; LEGER S; MANCINI JA; ONEILL G; OUELLET M; RODGER IW; THERIEN M; WANG Z; WEBB JK; WONG E; XU L; YOUNG RN; ZAMBONI R; PRASIT P; CHAN CC
      BIOCHEMICAL AND PHARMACOLOGICAL PROFILE OF A TETRASUBSTITUTED FURANONE AS A HIGHLY SELECTIVE COX-2 INHIBITOR

      British Journal of Pharmacology
    14. BLACK WC; BAYLY C; BELLEY M; CHAN CC; CHARLESON S; DENIS D; GAUTHIER JY; GORDON R; GUAY D; KARGMAN S; LAU CK; LEBLANC Y; MANCINI J; OUELLET M; PERCIVAL D; ROY P; SKOREY K; TAGARI P; VICKERS P; WONG E; XU L; PRASIT P
      FROM INDOMETHACIN TO A SELECTIVE COX-2 INHIBITOR - DEVELOPMENT OF INDOLALKANOIC ACIDS AS POTENT AND SELECTIVE CYCLOOXYGENASE-2 INHIBITORS

      Bioorganic & medicinal chemistry letters
    15. LEBLANC Y; BLACK WC; CHAN CC; CHARLESON S; DELORME D; DENIS D; GAUTHIER JY; GRIMM EL; GORDON R; GUAY D; HAMEL P; KARGMAN S; LAU CK; MANCINI J; OUELLET M; PERCIVAL D; ROY P; SKOREY K; TAGARI P; VICKERS P; WONG E; XU L; PRASTI P
      SYNTHESIS AND BIOLOGICAL EVALUATION OF BOTH ENANTIOMERS OF L-761,000 AS INHIBITORS OF CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2

      Bioorganic & medicinal chemistry letters
    16. KARGMAN S; CHARLESON S; CARTWRIGHT M; FRANK J; RIENDEAU D; MANCINI J; EVANS J; ONEILL G
      CHARACTERIZATION OF PROSTAGLANDIN G H SYNTHASE-1 AND SYNTHASE-2 IN RAT, DOG, MONKEY, AND HUMAN GASTROINTESTINAL TRACTS/

      Gastroenterology
    17. HUTCHINSON JH; CHARLESON S; EVANS JF; FALGUEYRET JP; HOOGSTEEN K; JONES TR; KARGMAN S; MACDONALD D; MCFARLANE CS; NICHOLSON DW; PIECHUTA H; RIENDEAU D; SCHEIGETZ J; THERIEN M; GIRARD Y
      THIOPYRANOL[2,3,4-C,D] INDOLES AS INHIBITORS OF 5-LIPOXYGENASE, 5-LIPOXYGENASE-ACTIVATING PROTEIN, AND LEUKOTRIENE C-4 SYNTHASE

      Journal of medicinal chemistry
    18. CHARLESON S; EVANS JF; LEGER S; PERRIER H; PRASIT P; WANG ZY; VICKERS PJ
      STRUCTURAL REQUIREMENTS FOR THE BINDING OF FATTY-ACIDS TO 5-LIPOXYGENASE-ACTIVATING PROTEIN

      European journal of pharmacology. Molecular pharmacology section
    19. MANCINI JA; COPPOLINO MG; KLASSEN JH; CHARLESON S; VICKERS PJ
      THE BINDING OF LEUKOTRIENE BIOSYNTHESIS INHIBITORS TO SITE-DIRECTED MUTANTS OF HUMAN 5-LIPOXYGENASE-ACTIVATING PROTEIN

      Life sciences
    20. VICKERS PJ; ADAM M; CHARLESON S; ABRAMOVITZ M; ONEILL G; MANCINI JA
      AMINO-ACID-RESIDUES OF 5-LIPOXYGENASE-ACTIVATING PROTEIN CRITICAL FORTHE BINDING OF LEUKOTRIENE BIOSYNTHESIS INHIBITORS

      Journal of lipid mediators
    21. PRASIT P; BELLEY M; BLOUIN M; BRIDEAU C; CHAN C; CHARLESON S; EVANS JF; FRENETTE R; GAUTHIER JY; GUAY J; GILLARD JW; GRIMM E; FORDHUTCHINSON AW; HUTCHINSON JH; FORTIN R; JONES TR; MANCINI J; LEGER S; MCFARLANE CS; PIECHUTA H; RIENDEAU D; ROY P; TAGARI P; VICKERS PJ; YOUNG RN; ZAMBONI R
      A NEW CLASS OF LEUKOTRIENE BIOSYNTHESIS INHIBITOR - THE DEVELOPMENT OF MK-0591

      Journal of lipid mediators
    22. WOODS JW; EVANS JF; ETHIER D; SCOTT S; VICKERS PJ; HEARN L; HEIBEIN JA; CHARLESON S; SINGER II
      5-LIPOXYGENASE AND 5-LIPOXYGENASE ACTIVATING PROTEIN ARE LOCALIZED INTHE NUCLEAR-ENVELOPE OF ACTIVATED HUMAN-LEUKOCYTES

      The Journal of experimental medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 02:47:17